- Report
- September 2026
- 289 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- August 2026
- 111 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 115 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- April 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,242GBP
- Report
- June 2026
- 200 Pages
Global
From €2717EUR$2,990USD£2,335GBP
- Report
- June 2026
- 200 Pages
Global
From €2717EUR$2,990USD£2,335GBP
- Report
- April 2026
- 200 Pages
Global
From €2717EUR$2,990USD£2,335GBP
- Report
- September 2026
- 185 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 195 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 185 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 199 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 197 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 190 Pages
Global
From €3221EUR$3,545USD£2,769GBP
€3579EUR$3,939USD£3,077GBP
- Report
- September 2026
- 286 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 377 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- September 2026
- 385 Pages
Global
From €5316EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP
- Report
- February 2026
- 250 Pages
Global
From €4080EUR$4,490USD£3,507GBP

The Neurological Drug market is composed of drugs used to treat diseases and disorders of the Central Nervous System (CNS). These drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and stroke. CNS drugs are also used to treat psychiatric disorders, such as depression, anxiety, and schizophrenia. These drugs are typically administered orally, intravenously, or intramuscularly.
The Neurological Drug market is highly competitive, with many large pharmaceutical companies competing for market share. Companies such as Pfizer, Merck, Novartis, and GlaxoSmithKline are some of the major players in the market. Other companies, such as Eli Lilly, AstraZeneca, and Sanofi, also have a presence in the market. Additionally, there are many smaller companies that specialize in the development and manufacture of CNS drugs. Show Less Read more